Elora Gupta

Title: Elora Gupta: Innovator in Cancer Treatment

Introduction

Elora Gupta is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of drug combinations. Her work focuses on reducing the side effects associated with camptothecin drugs, which are commonly used in chemotherapy.

Latest Patents

Elora Gupta holds a patent for her invention titled "Camptothecin drug combinations and methods with reduced side effects." This invention provides methods and combination formulations and kits designed to reduce the toxicity of camptothecin drugs, such as irinotecan (CPT-11). The patent discloses therapeutics and treatment methods that employ these drugs in combination with agents that increase conjugative enzyme activity or glucuronosyltransferase activity. Additionally, it includes agents that decrease biliary transport protein activity, such as cyclosporine A. The resultant effects of these combinations are aimed at decreasing the significant side effects previously associated with treatment using these drugs.

Career Highlights

Elora Gupta has established herself as a key figure in the pharmaceutical industry. Her innovative approach to drug formulation has garnered attention and respect from her peers. She is currently associated with Arch Development Corporation, where she continues to advance her research and contribute to the development of effective cancer treatments.

Collaborations

Elora collaborates with notable professionals in her field, including her coworker Mark J Ratain. Their combined expertise enhances the potential for groundbreaking advancements in cancer therapy.

Conclusion

Elora Gupta's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her dedication to reducing the side effects of chemotherapy drugs is paving the way for more effective and safer treatment options for patients.